Be The Investor

After Hours7,616.25+0.63%

Nasdaq Composite

25,372.01+0.83%

After Hours25,504.90+0.52%

51,786.72-0.38%

After Hours52,313.62+1.02%

After Hours2,845.70+1.18%

78,323.13+1.27%

US 10-Year Treasury Yield

Home›Stocks›BBIO

Overview Chart News Financials Business Model Competitors Statistics Analysis Earnings Valuation Holders Options Insiders Forecast Compare FAQ

BridgeBio Pharma, Inc.

BBIO

NASDAQ

USReal-Time Price

$74.03USD

-0.96 (-1.29%)Today

$74.33+0.30 (+0.41%)Pre-MarketLast quote · Nov 4, 2026, 4:00 AM ET

BTI Score

BASIC required or higher

BTI Fair Market Cap

$8.58B

Revenue-based (growth phase)

Biotechnology

High Risk

BridgeBio Pharma, Inc. (BBIO) Business Model

How does BridgeBio Pharma, Inc. (BBIO) make money? A breakdown of revenue segments, margins, competitive moat and the unit economics behind the business.

Error loading business model: Sign in to load this business model